You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The funding, part of a larger initiative by Genome Canada, will support two studies in British Columbia that will evaluate genomics in healthcare.
British Columbia is incorporating genomics into its tracking of the ongoing COVID-19 outbreak, Business in Vancouver reports.
The British Columbia Centre for Disease Control will use genomic analysis to identify the origins and spread of SARS-CoV-2, formerly known as 2019-nCoV.
Researchers from UBC, the BC Centre for Disease Control, and elsewhere will conduct a multi-omics study of the foodborne pathogen.
Genome Canada and its partners recently funded two new initiatives with C$255 that will back precision medicine, genomics, and technology development.
DivSeek was established in 2015 to support the genomic characterization of the 7 million crop accessions currently being stored at gene banks around the world.
Microbiome Insights provides next-generation sequencing-based analytical testing and consulting services to microbiome researchers in academia and industry.
The two projects aim to use genomics to prevent the spread of drug-resistant bacteria and expand the use of genomic testing in cancer, respectively.
The project aims to developa system to automate the coring of tumor samples based on identified targets for DNA and RNA extraction.
Despite highly effective HCV drugs, testing for resistance mutations is important to prevent the spread of resistant strains and to tailor treatment.
Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.
Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.
The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.
This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.